Skip to main content
. 2020 Nov 17;11:601555. doi: 10.3389/fmicb.2020.601555

Figure 7.

Figure 7

Inhibition of HCMV replication by TAT-I24. (A) MRC-5 cells were transduced with recombinant reporter construct AAV-GLuc-3B and treated on the next day with TAT (48–60) or TAT-I24 and infected with the HCMV strain TB40 at a MOI of 0.2. Results shown are Gaussia luciferase levels in the supernatants (mean ± SD from triplicate wells) 3 days after infection expressed as % of vehicle-treated cells. (B) Total RNA was isolated from cells from the replicon assay. Results shown are UL44 mRNA levels normalized to GAPDH mRNA levels expressed as % of control.